BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Already Owning 40.8% of BlueRock Therapeutics, Bayer Buys Rest of Company for $600 Million

  Under the terms of the acquisition, Bayer is buying the rest of the company for $240 million up front with an additional $360 million in various development milestones. This will correspond with the company’s value of about $1 billion.

  August 8, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  BioCapital

  CMS Releases New Rules Overseeing CAR-T Immuno-Oncology Therapy

  The Centers for Medicare and Medicaid Services announced the agency would cover CAR-T so patients would have “consistent and predictable access” to the therapy.

  August 8, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  Akcea and Ionis Gear Up for Second Attempt at Getting Waylivra FDA Approval

  Waylivra was rejected by the FDA last year but gained approval in Europe in May. The publication of final Phase III data in the New England Journal of Medicine could support a potential bid for regulatory approval in the U.S.

  August 8, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Research Roundup: Possible Melanoma Vaccine and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  August 8, 2019

   · 

  4 min read

   · 

  Mark Terry
• Business

  MyoKardia Reports Second Quarter 2019 Financial Results

  MyoKardia, Inc. reported financial results for the second quarter ended June 30, 2019.

  August 8, 2019

   · 

  10 min read
• Job Trends

  Brain Stimulation for PTSD Patients

  For 8-million adults who suffer from post-traumatic stress disorder in any given year, medication and cognitive therapy have been the treatment protocol.

  August 8, 2019

   · 

  2 min read
• Business

  Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance

  Vericel Corporation reported financial results for the second quarter ended June 30, 2019, and recent business highlights.

  August 8, 2019

   · 

  10 min read
• Genetown

  Shimmer Wins Two GHP International Life Sciences Awards for its Wearable Sensor Technology

  Awards recognize Shimmer’s advances in developing wearable sensors tailored for specific uses, such as clinical trials and consumer neuroscience research

  August 8, 2019

   · 

  3 min read
• Biotech Beach

  Developing targeted therapy for infants with leukemia

  This combination targeted therapy may offer hope to infants diagnosed with a deadly type of leukemia

  August 8, 2019

   · 

  4 min read
• Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

  Integrated package of new and established services saves time and minimizes risks

  August 8, 2019

   · 

  3 min read